Samsung Galaxy Mega rumored to fill in the last gaps between phablet and tablet
April 2, 2013
Samsung took some flak when it launched its first phablet, the Galaxy Note. “A giant-sized phone with a stylus? HA!” ... then the device turned out to be quite good ... and then it sold millions of units. Who’s laughing now? So don’t blame us for keeping an open mind about the company’s rumored gigantophone, the Samsung Galaxy Mega.
According to SamMobile, Samsung has rebranded the previously-leaked “Galaxy Fonblet” (whew!) into the Galaxy Mega. What is it, you ask? We’re actually talking about two devices: the Galaxy Mega 5.8, with a 5.8-inch screen, and the Galaxy Mega 6.3, with – you guessed it – a 6.3-inch screen.
The unconfirmed phones would be significantly bigger than the Galaxy Note I and II. But previous leaks suggest that – unlike the stylus-toting phablets – these passengers aren’t sailing first class. The Mega 5.8 might actually be a cellular-enabled version of the Galaxy Player 5.8, a huge media player sold in Korea.
The Mega was previously rumored to only have 960 x 640 resolution, as well as dual SIM cards, and either Android 4.1.2 or 4.2.1. Other Galaxy Player specs that may or may not show up in the Mega include a 3-megapixel camera and a 2,500 mAh battery.
If these rumored components hold up, then we’re looking at a decidedly mid-range device. It could also potentially have a limited release, and only sell in Europe.
About that Note 3
There is one more curiosity about the 6.3-inch edition of the Galaxy Mega. That GamePad controller accessory that Samsung teased at its Galaxy S4 event supports devices up to 6.3-inches. Many pundits had assumed that that was pointing squarely at the Galaxy Note 3 ... and it still could be. But that 6.3-inch Mega makes a less gigantic Note 3 a bit more likely.
We should find out more in the coming months. The two humongo-phones are rumored to release in late May or June. Keep in mind, though, that – despite the source’s solid track record – all of this is very much unconfirmed.